The company is one of the top 5 largest Antibiotic Active Pharmaceutical Ingredient companies in the world having 3 APIs & 3 Formulations manufacturing facilitates. The company has two R&D centers. All its plants are approved by the regulatory agencies of Advanced Countries like USFDA, MHRA, TGA….

The company has over 3000 employees including 600+ scientists & technologist who are working in their R&D for development New Chemical entity, ANDA & Process development.

The company has manufacturing facility in China and exclusive joint venture marketing & distribution agreement across the world incl. USA & Canada.

In Regulated Generics Business, in US, the company has filed 46 DMF's and 40 ANDA's cumulative till date with 16 DMF's and 14 ANDA's filed in 2006-07 alone.

The company has also filed 11 dossiers in the European Union & Australia, New Zealand in 2006-07 (cumulative 14 nos).

The company is a totally integrated pharmaceutical company having world class manufacturing facilities creating value to its customers from “Discovery to Delivery” and has ISO 9001:2000 certification from KPMG.

• Increase in inventory turnover ratio (from 3.7 to 4.6 times)
  
• Reduction in Spare inventory (by 26%)
  
• Capacity utilization improving from 85 to 92%
  
• Reduction in idle time due to break down (by 6%)
  
• Reduction in FG inventory from 45 to 17 days
  
• The idle time due to RM Shortage also showed a reduction of around 5%
  
• The response time to customer reduced from 7 days to 1 day